KOR Medical launches cannabinoid product line

Listen to this article

Charleston-based KOR Medical launched its cannabinoid physical and mental wellness product line across the United States today.

Products include sprays, strips and transdermal creams made with cannabidiol, cannabinol and cannabigerol oils used as an aid for sleeping, relaxation or pain relief. All sublingual products, or those designed to be absorbed under the tongue, are nano-emulsified to accelerate absorption rate within the body, the company said.

The neuropathic industry has put the cannabis flower to use for thousands of years, according to KOR, in the production of over 100 cannabinoids including cannabidiol, cannabinol and cannabigerol.

Cannabidiol is a highly-purified non-intoxicating cannabis derivative associated with analgesic, anti-inflammatory and chemopreventive properties, according to the National Cancer Institute. Cannabigerol is also associated with antibacterial, anti-inflammatory and neuroprotective benefits, the National Institutes of Health said.

In an effort to deliver cannabinoids at “the right amount for the right individual at the right time,” the company has partnered with Leaf411, which offers a free, tailored support service that connects customers with a cannabis-trained registered nurse.

Research is underway to see if and how these molecules can impact anxiety, insomnia, chronic pain, anti-inflammatory diseases, seizures and other neurological conditions like Alzheimer’s and Parkinson’s disease.

KOR Medical was founded earlier this year by Charleston diagnostic company Vikor Scientific.

KOR Medical hired on four senior executives with experience in the clinical cannabis sector, including the company’s COO and executive vice president, Joseph Strauss earlier this year.

Strauss has worked in the medicinal cannabis industry across multiple states including Oregon, California, Colorado and Florida.